Ironwood Pharma (IRWD) Posts Q2 Loss of 57c/Share; Affirms Outlook
Tweet Send to a Friend
Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.57), $0.11 better than the analyst estimate of ($0.68). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
